HealthTech

Major FDA staff cuts would slow drug reviews, experts say

Major FDA staff cuts would slow drug reviews, experts say

Feb 9, 2025 0

The Trump administration's reported plans to potentially lay off thousands of FD...

Post-Hoc: China tensions both help and hurt Illumina

Post-Hoc: China tensions both help and hurt Illumina

Feb 9, 2025 0

In the souring US-China relationship, there are winners and losers. DNA sequenci...

Sanofi, AstraZeneca back Teva's call to rehear case on patent listings

Sanofi, AstraZeneca back Teva's call to rehear case on ...

Feb 9, 2025 0

Sanofi, AstraZeneca and two leading trade groups want clarity around an appellat...

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims

Senators ask FDA to dig into 'misleading' Super Bowl ad...

Feb 9, 2025 0

Sens. Dick Durbin (D-IL) and Roger Marshall (R-KS) are calling on the FDA to tak...

Q4 earnings updates; Biogen details revised research strategy; RFK Jr. advances out of Senate committee; and more

Q4 earnings updates; Biogen details revised research st...

Feb 9, 2025 0

Welcome back to Endpoints Weekly! Our team tracked fourth-quarter earnings repor...

AbbVie wins FDA approval for new antibiotic

AbbVie wins FDA approval for new antibiotic

Feb 9, 2025 0

The FDA approved AbbVie and Pfizer's drug Emblaveo in combination with an older ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.